Literature DB >> 26147383

Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial.

Suzanne C van Dijk1, Anke W Enneman, Karin M A Swart, Janneke P van Wijngaarden, Annelies C Ham, Elske M Brouwer-Brolsma, Nikita L van der Zwaluw, Henk J Blom, Edith J Feskens, Johanna Marianna Geleijnse, Natasja M van Schoor, Rosalie A M Dhonukshe-Rutten, Renate T de Jongh, Paul Lips, Lisette C P G M de Groot, Andre G Uitterlinden, Yvo M Smulders, Anton H van den Meiracker, Francesco U S Mattace Raso, Nathalie van der Velde.   

Abstract

INTRODUCTION: Hyperhomocysteinemia is an important cardiovascular risk indicator in the oldest old, and is associated with elevated arterial stiffness in this age group. Since several intervention trials reported a lack of benefit of B-vitamin supplementation on cardiovascular outcomes, we aimed to investigate the effect of B-vitamin supplementation on arterial stiffness and atherosclerosis in hyperhomocysteinemic elderly patients.
METHODS: The B-PROOF study is a double-blind, randomized controlled trial, including 2919 elderly aged at least 65 years, with hyperhomocysteinemia (12-50  μmol/l), treated with B-vitamins (500  μg vitamin B12 and 400  μg folic acid) or placebo for 2 years. In a subgroup (n = 569), the effect of B-vitamins on pulse wave velocity (PWV) was investigated as a measurement of arterial stiffness. To measure atherosclerosis, carotid intima-media thickness (IMT) measures had been used. Incidents of cardiovascular and cerebrovascular events were determined via structured questionnaires, and blood pressure was also measured.
RESULTS: Compared to placebo, B-vitamin supplementation lowered serum homocysteine by 3.6  μmol/l (P < 0.001). Analysis of covariance showed no effect of supplementation on PWV levels, and this was not different for patients without increased arterial stiffness at baseline. Furthermore, no effect on carotid IMT was observed. DISCUSSION: Vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly patients have no effect on PWV or carotid IMT. Further research will still be necessary to unravel the effects and pathways of homocysteine-lowering treatment on cardiovascular outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26147383     DOI: 10.1097/HJH.0000000000000647

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

2.  Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis.

Authors:  J V Zhao; C M Schooling
Journal:  Eur J Clin Nutr       Date:  2016-11-30       Impact factor: 4.016

3.  Arterial stiffness is not associated with bone parameters in an elderly hyperhomocysteinemic population.

Authors:  S C van Dijk; R T de Jongh; A W Enneman; A C Ham; K M A Swart; J P van Wijngaarden; N L van der Zwaluw; E M Brouwer-Brolsma; N M van Schoor; R A M Dhonukshe-Rutten; P Lips; C P G M de Groot; Y M Smulders; H J Blom; E J Feskens; J M Geleijnse; A H van den Meiracker; F U S Mattace Raso; A G Uitterlinden; M C Zillikens; N van der Velde
Journal:  J Bone Miner Metab       Date:  2015-03-25       Impact factor: 2.626

4.  Physical Fitness, Activity and Hand-Grip Strength Are Not Associated with Arterial Stiffness in Older Individuals.

Authors:  S C van Dijk; K M A Swart; A C Ham; A W Enneman; J P van Wijngaarden; E J Feskens; J M Geleijnse; R T de Jongh; H J Blom; R A M Dhonukshe-Rutten; L C P G M de Groot; N M van Schoor; P Lips; A G Uitterlinden; F U S Mattace Raso; Y M Smulders; A H van den Meiracker; N van der Velde
Journal:  J Nutr Health Aging       Date:  2015-08       Impact factor: 4.075

Review 5.  Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness.

Authors:  Ioana Mozos; Dana Stoian; Constantin Tudor Luca
Journal:  Dis Markers       Date:  2017-01-12       Impact factor: 3.434

6.  Natural approaches in metabolic syndrome management.

Authors:  Angelo Maria Patti; Khalid Al-Rasadi; Rosaria Vincenza Giglio; Dragana Nikolic; Carlo Mannina; Giuseppa Castellino; Roberta Chianetta; Maciej Banach; Arrigo F G Cicero; Giuseppe Lippi; Giuseppe Montalto; Manfredi Rizzo; Peter P Toth
Journal:  Arch Med Sci       Date:  2017-07-19       Impact factor: 3.318

7.  Multivariate Analysis of Influence of Vitamin Intake on Vascular Function Parameters by Sex in the General Spanish Population: EVA Study.

Authors:  Maria C Patino-Alonso; Marta Gómez Sánchez; Leticia Gómez Sánchez; Rosario Alonso-Domínguez; Natalia Sánchez-Aguadero; Benigna Sánchez Salgado; Emiliano Rodríguez Sánchez; Luis García Ortiz; Manuel A Gómez-Marcos
Journal:  Nutrients       Date:  2020-02-28       Impact factor: 5.717

Review 8.  DNA Methylation Aberrant in Atherosclerosis.

Authors:  Yao Dai; Danian Chen; Tingting Xu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

9.  Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals.

Authors:  Sangwoo Park; Gyung-Min Park; Jinhee Ha; Young-Rak Cho; Jae-Hyung Roh; Eun Ji Park; Yujin Yang; Ki-Bum Won; Soe Hee Ann; Yong-Giun Kim; Shin-Jae Kim; Sang-Gon Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

10.  Association of homocysteine with carotid-femoral pulse wave velocity in a southern Chinese population.

Authors:  Tingjun Wang; Guoyan Xu; Xiaoqi Cai; Jin Gong; Qunfang Xie; Liangdi Xie
Journal:  Aging (Albany NY)       Date:  2019-11-11       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.